Harald Schmidt, born 1959, is trained both as medical doctor and pharmacist with both board certificates. He is professor of pharmacology & personalised medicine at the Cardiovascular Research Institute Maastricht, Netherlands, Honorary Fellow at the Baker IDI, Melbourne, Australia. He leads a European Research Council research program as Advanced Investigator, Europe’s most prestigious research award, and a European Science Foundation COST Action on Systems Medicine, is board member of the Maastricht Institute for Advanced Studies and co-leads the medical faculty’s innovation platform. Before his current appointment, he worked in Australia (Monash University), Germany and USA where he founded and directed Monash University’s Centre for Vascular Health, had different chairs in pharmacology, directs a drug discovery CRO at TransMIT, and co-founded and for two years led as CEO Vasopharm GmbH, a drug discovery company now entering into phase III clinical development of an NO synthase inhibitor. His research is highly translational and focuses on cardiovascular and neurological disease mechanisms including NO, cGMP and reactive oxygen, target validation, drug and biomarker discovery, personalised medicine and recently on network and systems medicine. Moreover he has conducted two systematic-review meta-analysis studies showing lack of study quality and publication bias which lead to his project pre-clinicaltrials.org, a voluntary database for unpublished negative (and positive) data to overcome publication bias and facilitate systematic reviews and meta-analyses. Professor Schmidt has published 220 peer-reviewed papers, reviews, books and patents (Hirsch-index 82). He is a member of the European Society of Cardiology Working Group - Cardiovascular Pharmacology and Drug Therapy, Section Editor of the Public Library of Science. He has been awarded the Roche Molecular Biochemicals Research Prize for Cell Biology, the Phoenix Research Prize in Pharmacy, and the Pro Scientia Prize and is active in community engagement in different leadership roles via Rotary International and pharmaciens sans frontièrs.